These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2263592)

  • 61. The determination of an empirical correction factor to deal with the problem of nucleolar splitting in neuronal counts.
    Coggeshall RE; Chung K
    J Neurosci Methods; 1984 Feb; 10(2):149-55. PubMed ID: 6748736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined staging and grading of renal cell carcinoma.
    Hermanek P; Sigel A; Chlepas S
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976; 87(2):193-6. PubMed ID: 136826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel nucleolar biomarker in plant and animal cells for assessment of substance cytotoxicity.
    Arkhipchuk VV; Garanko NN
    Environ Toxicol; 2002; 17(3):187-94. PubMed ID: 12112626
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Precision for the Conventional.
    Smith SC; Wobker SE
    Am J Clin Pathol; 2021 Sep; 156(4):495-496. PubMed ID: 33942844
    [No Abstract]   [Full Text] [Related]  

  • 65. Renal adenocarcinoma. Evaluation of malignancy on a cytologic basis: a comparative cytologic and histologic study.
    von Schreeb T; Franzén S; Ljungqvist A
    Scand J Urol Nephrol; 1967; 1(3):265-9. PubMed ID: 5588771
    [No Abstract]   [Full Text] [Related]  

  • 66. Solitary distant metastases from unsuspected renal carcinomas.
    CHUTE R; IRELAND EF; HOUGHTON JD
    J Urol; 1958 Dec; 80(6):420-4. PubMed ID: 13631756
    [No Abstract]   [Full Text] [Related]  

  • 67. [On histologic prognosis in renal cancer].
    PLAUCHU M; POTTON F
    Lyon Chir; 1951; 46(6):715-24. PubMed ID: 14862262
    [No Abstract]   [Full Text] [Related]  

  • 68. Words of wisdom. Re: Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Remzi M
    Eur Urol; 2009 Mar; 55(3):751-2. PubMed ID: 19650211
    [No Abstract]   [Full Text] [Related]  

  • 69. Nucleolus assessment in invasive breast carcinoma, an objective parameter for histological grading.
    Öztürk SD; Öztürk Ç; Okcu O; Şen B; Bedir R
    Turk J Med Sci; 2022 Aug; 52(4):975-983. PubMed ID: 36326384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
    Helpap B; Loesevitz L; Bulatko A
    Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histopathologic prognostic indicators for renal cell carcinoma.
    Delahunt B
    Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nucleolar grading of renal cancer. Correlation of frequency and localization of nucleoli to histologic and cytologic grading and stage of renal cell carcinomas.
    Helpap B; Knüpffer J; Essmann S
    Mod Pathol; 1990 Nov; 3(6):671-8. PubMed ID: 2263592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Histological and cytological (nucleolar) grading of renal cell carcinoma].
    Helpap B; Knüpffer J; Essmann S
    Verh Dtsch Ges Pathol; 1989; 73():400-4. PubMed ID: 2482626
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Histological malignancy grade of renal cancer: karyo- and stereometric analysis].
    Iurin AG; Koval'skiĭ GB
    Arkh Patol; 2009; 71(2):13-8. PubMed ID: 19507571
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.